Stock Research: Bausch Health Companies

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Bausch Health Companies

NYSE:BHC CA0717341071
52
  • Value
    48
  • Growth
    53
  • Safety
    Safety
    98
  • Combined
    89
  • Sentiment
    8
  • 360° View
    360° View
    52
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Bausch Health Companies Inc. is a global specialty pharmaceutical and medical device company. It operates in the pharmaceutical and medical device industries, with brands like Bausch + Lomb. It operates globally, including the U.S. and internationally. In the last fiscal year, the company had a market cap of $2378 million, profits of $6843 million, and revenue of $9625 million, with 20700 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 52 (better than 52% compared with alternatives), overall professional sentiment and financial characteristics for the stock Bausch Health Companies are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Bausch Health Companies. The consolidated Value Rank has an attractive rank of 98, which means that the share price of Bausch Health Companies is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 98% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 53, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 8. Professional investors are more confident in 92% other stocks. Worryingly, the company has risky financing, with a Safety rank of 48. This means 52% of comparable companies have a safer financing structure than Bausch Health Companies. ...read more

more
Index
TSX Composite
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
98 100 100 100
Growth
53 17 43 47
Safety
Safety
48 39 26 8
Sentiment
8 10 28 14
360° View
360° View
52 21 37 26
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
1 1 5 53
Opinions Change
31 28 75 35
Pro Holdings
n/a 76 91 74
Market Pulse
3 1 3 2
Sentiment
8 10 28 14
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
98 100 100 100
Growth
53 17 43 47
Safety Safety
48 39 26 8
Combined
89 55 62 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
100 96 100 100
Price vs. Earnings (P/E)
97 95 95 84
Price vs. Book (P/B)
89 96 95 98
Dividend Yield
1 1 1 1
Value
98 100 100 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
31 24 38 21
Profit Growth
38 50 49 34
Capital Growth
47 25 42 79
Stock Returns
79 39 65 73
Growth
53 17 43 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
5 7 5 9
Refinancing
85 65 69 5
Liquidity
54 53 49 61
Safety Safety
48 39 26 8

Similar Stocks

Discover high‑ranked alternatives to Bausch Health Companies and broaden your portfolio horizons.

Canadian Utilities

TSX:CU
Country: Canada
Industry: Multi-Utilities
Size: Medium
Full Stock Analysis

Russel Metals

TSX:RUS
Country: Canada
Industry: Trading & Distribution
Size: Medium
Full Stock Analysis

Whitecap Resources

TSX:WCP
Country: Canada
Industry: Oil & Gas Production
Size: Medium
Full Stock Analysis

The North West

TSX:NWC
Country: Canada
Industry: Food Retail
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.